Bliss GVS Pharma is a finished-dose manufacturer based in India. It appears in 165 regulatory filings across 14 regulators, without an active US DMF or CEP on file. Its filings concentrate with ZAMRA (ZM), NAFDAC (NG) and TMDA (TZ). Its GMP standing is certified by CDSCO (India), TMDA (TZ) and FDA (GH), among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 17 March 2023 as VAI. Customs aggregates show $65.5M of exports covering 2,638 molecules to 56 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Maharashtra, United Arab Emirates | Not on file |
| Palghar, India | 3007068506 |
| Palghar, India | 3008380269 |
| vapivapi 396 195 valsad, India | Not on file |
| ay stationvillage ranoli 391 350vadodara, India | Not on file |
| G.I.D.C., India | Not on file |
1 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| ZAMRA (ZM) | 51 | None |
| NAFDAC (NG) | 31 | 1 |
| TMDA (TZ) | 21 | 2 |
| FDA (GH) | 18 | 2 |
| MINSA (CR) | 11 | None |
| DAV (Vietnam) | 10 | None |
| CDSCO (India) | None | 4 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $65.5M | 56 |
| 2024 | Not reported | $74.2M | 52 |
| 2023 | Not reported | $69.0M | 58 |
| 2022 | Not reported | $69.8M | 53 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Bliss GVS Pharma comes back tiered against every other supplier able to file there.
Start for free